ArticlePatient preference and adherence2021

Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients - Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting - Results from the Non-Interventional Study PERFECT.

Borries Kukowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.